That’s a fair point WAG but I’m more interested in Taysha’s share price getting smacked down ~25% on questionable trial results and NEU’s share price getting smacked down a similar percentage on fantastic trial results in PHS. Apples and oranges I know but it’s a funny old market….
While I’m here, the FDA has a new program called Operation Warp Speed for rare disease development I might write to Jon about it.
https://www.fiercebiotech.com/research/fda-selects-denali-neurogene-larimar-and-grace-sciences-rare-disease-therapy-pilot
That’s a fair point WAG but I’m more interested in Taysha’s...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |